Skip to content
Clinical Trials – home
GreeceBack to Greece

Clinical trials in Kallithea – page 35

1 033 clinical trials in Kallithea, Greece. Every trial is listed in the EU Clinical Trials Register and updated daily.

GreeceOur site in GreeceΚλινικεσΔοκιμεσ.gr(opens in a new tab)
Kallithea at a glance
1 033
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

1 033 trials in Kallithea

Open in trial search

Thalassaemia beta+2

Not yet recruiting

Phase 3 Study of Mitapivat to Reduce Transfusions in Children with Alpha or Beta Transfusion‑Dependent Thalassemia

Investigational
Countries:GreeceGreece
  • Participants:0–17 years
  • Substances:Mitapivat
  • Sponsor:Agios Pharmaceuticals Inc.

Amyloidosis

Not yet recruiting

Evaluation of belantamab mafodotin plus drug combination in adult patients with newly diagnosed light chain amyloidosis

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years
  • Substances:Bortezomib
  • Sponsor:Glaxosmithkline Research & Development Limited

Rhinitis

Not yet recruiting

Randomized study of ketotifen nasal spray (0.025% and 0.050%) versus sodium cromoglicate nasal spray in patients with rhinitis

Registered drug
Countries:GreeceGreece
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Ketotifen
  • Sponsor:Eudemus Pharmaceuticals Limited

Ischaemic stroke

Not yet recruiting

Phase 2 Study of RADAMTS13 in Adults with Acute Ischemic Stroke

Registered drug
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:RADAMTS13
  • Sponsor:Takeda Development Center Americas Inc.

Sepsis

Not yet recruiting

Clarithromycin to prevent secondary infections in adult patients with community-acquired pneumonia-related sepsis

Registered drug
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Clarithromycin
  • Sponsor:Hellenic Institute For The Study Of Sepsis

Interstitial lung disease+2

Not yet recruiting

Long‑term Safety and Tolerability of Admilparant in Adults with Idiopathic or Progressive Pulmonary Fibrosis

InvestigationalNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Admilparant
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Bacterial infection+1

Not yet recruiting

A study to evaluate the use of meropenem to reduce the risk of sepsis in patients with suspected infection in the emergency department

Registered drug
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Meropenem Anhydrous
  • Sponsor:Hellenic Institute For The Study Of Sepsis

Embolism

Not yet recruiting

A study to compare REGN7508 and acetylsalicylic acid for preventing blood clots in adults undergoing elective total knee replacement.

Registered drug
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Regeneron Pharmaceuticals Inc.

Pulmonary fibrosis

Not yet recruiting

A study to evaluate the effectiveness and safety of admilparant in patients with progressive pulmonary fibrosis

Investigational
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Admilparant
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

A Study of Linvoseltamab Alone and Linvoseltamab with Carfilzomib Compared to Standard Treatment in Adults with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Aciclovir
  • Sponsor:Regeneron Pharmaceuticals Inc.

Ischaemic stroke

Not yet recruiting

Study of Drug Combination with Amodiaquine and Potassium Canrenoate Plus Exenatide or Glibenclamide for Patients with Acute Ischemic Stroke

InvestigationalNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Amodiaquine
  • Sponsor:Genesis Pharma S.A.

Systemic lupus erythematosus+1

Not yet recruiting

A Study of Obecabtagene Autoleucel for Patients with Severe Lupus and Active Kidney Inflammation Not Responding to Standard Treatment

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years
  • Substances:Cyclophosphamide
  • Sponsor:Autolus Limited

Other cities in Greece

The busiest research cities in the country

All 48 cities in Greece

Clinical research in Kallithea

What the registry says about research in the country

01 Pulmonary Arterial Hypertension Research

Multiple clinical trials focusing on innovative treatments for Pulmonary Arterial Hypertension (PAH), including evaluation of new medications like seralutinib and ralinepag. Studies aim to assess long-term safety and effectiveness of various therapeutic approaches.

  • Inhaled treatments assessment
  • Long-term safety studies
  • Exercise capacity improvement

Research includes both oral and inhaled medication delivery methods to optimize patient outcomes.

02 Cardiac Structure Studies

Investigations centered on Hypertrophic Cardiomyopathy, examining innovative treatments' effects on heart structure and function. Studies evaluate medications like mavacamten and aficamten for both obstructive and non-obstructive forms.

  • Cardiac imaging analysis
  • Symptom management
  • Exercise capacity evaluation

Research focuses on improving patient health status and cardiac structural modifications.

03 Cardiovascular Prevention

Clinical research examining preventive treatments for Atrial Fibrillation and related cardiovascular conditions. Studies evaluate new anticoagulation approaches and disease progression markers.

  • Stroke prevention
  • Systemic embolism prevention
  • Comparative treatment studies

Trials aim to advance therapeutic options for preventing cardioembolic events.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.